Ganga Pharmaceuticals Ltd — Important, 16-03-2026: Company Update

Ganga Pharmaceuticals has announced a special window for shareholders to re-lodge requests for transfer and dematerialisation of physical securities. This facility assists investors whose share transfers were previously unfulfilled or rejected due to various reasons, particularly for shares bought before April 2019. The window, open for a year, allows shareholders to convert their physical holdings to electronic format. Investors should note that shares dematerialized through this process will be locked in for one year, restricting their transfer, lien, or pledge during this period. This initiative helps streamline shareholding and ensures compliance.